PHAS
RhumbLine Advisers’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-10,492
| Closed | -$36K | – | 3160 |
|
|
2021
Q1 | $36K | Hold |
10,492
| – | – | ﹤0.01% | 2983 |
|
|
2020
Q4 | $35K | Buy |
+10,492
| New | +$35K | ﹤0.01% | 3030 |
|
|
2020
Q3 | – | Sell |
-11,932
| Closed | -$55K | – | 3056 |
|
|
2020
Q2 | $55K | Buy |
+11,932
| New | +$55K | ﹤0.01% | 3029 |
|
|
2019
Q4 | – | Sell |
-10,182
| Closed | -$42K | – | 2948 |
|
|
2019
Q3 | $42K | Sell |
10,182
-125
| -1% | -$516 | ﹤0.01% | 2934 |
|
|
2019
Q2 | $135K | Buy |
+10,307
| New | +$135K | ﹤0.01% | 2878 |
|